Hydrocortisone pharmacokinetics
Showing 26 - 50 of >10,000
Ocular Inflammation, Ocular Prostheses Trial in Rennes (Hydrocortisone, Dexamethasone, Povidone)
Not yet recruiting
- Ocular Inflammation
- Ocular Prostheses
- Hydrocortisone
- +2 more
-
Rennes, FranceCentre Hospitalier Universitaire de Rennes _ Pontchaillou
Dec 20, 2022
TMJ Pain Trial (Hydrocortisone 2.5%, Diclofenac 1% topical)
Not yet recruiting
- TMJ Pain
- Hydrocortisone 2.5%
- Diclofenac 1% topical
- (no location specified)
Apr 3, 2023
Scar, Hydrocortisone, Iontophoresis Trial in Damietta (Iontophoresis, Phonophoresis, traditional PT program)
Completed
- Scar
- +3 more
- Iontophoresis
- +2 more
-
Damietta, EgyptOutpatient clinic, Faculty of Physical Therapy, Horus University
Mar 19, 2022
Septic Shock Trial in Pécs (Vitamin C)
Completed
- Septic Shock
- Vitamin C
-
Pécs, Baranya, HungaryDepartment of Anaesthesia and Intensive Therapy University of Pe
Nov 28, 2023
Congenital Adrenal Hyperplasia Trial in Japan, United States (Chronocort, Cortef)
Recruiting
- Congenital Adrenal Hyperplasia
-
Orange, California
- +21 more
Nov 21, 2022
Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)
Not yet recruiting
- Leukemia
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Dec 23, 2022
Sepsis, Septic Shock, HIV Trial in Kampala (Vitamin C, Vitamin B1)
Recruiting
- Sepsis
- +2 more
- Vitamin C
- Vitamin B1
-
Kampala, Uganda
- +1 more
Sep 6, 2021
Hypoglycaemia (Low Blood Sugar) in Diabetes and Adrenal Failure
Not yet recruiting
- Diabetes Mellitus, Type 1
- +2 more
- Continuous Glucose Monitoring
-
London, United KingdomCharing Cross Hospital, Imperial College Healthcare NHS Trust
Apr 13, 2023
Alcohol Drinking, Drinking Behavior, Episodic Memory Trial in New Haven (Hydrocortisone 20 MG, Placebo)
Completed
- Alcohol Drinking
- +3 more
- Hydrocortisone 20 MG
- Placebo
-
New Haven, ConnecticutYale University
Jun 1, 2022
Addison's Disease Trial in London (Solu-Cortef 100 MG Injection, Hydrocortisone 100mg/ml)
Recruiting
- Addison's Disease
- Solu-Cortef 100 MG Injection
- Hydrocortisone 100mg/ml
-
London, United KingdomThe London Clinic
Apr 22, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Dasatinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 20, 2023
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Ruxolitinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 16, 2023
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Decitabine
- +3 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 22, 2023
Cardiogenic Shock Trial in France (Hydrocortisone + Flucortac, Placebo)
Recruiting
- Cardiogenic Shock
- Hydrocortisone + Flucortac
- Placebo
-
Paris, Ile De France, France
- +20 more
Jun 13, 2022
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Trametinib
- +4 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Dec 13, 2022
Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate)
Active, not recruiting
- Congenital Adrenal Hyperplasia
- Abiraterone acetate
-
Los Angeles, California
- +3 more
Feb 22, 2022
Prostate Cancer Trial in United States (177Lu-J591, Ketoconazole, Hydrocortisone)
Active, not recruiting
- Prostate Cancer
- 177Lu-J591
- +3 more
-
Los Angeles, California
- +8 more
Mar 25, 2022
Glucocorticoid Effect Trial in Basel (Metyrapone 250 mg Oral Tablets, Hydrocortisone 19.9mg s.c., pulsatile with a flow rate of
Recruiting
- Glucocorticoid Effect
- Metyrapone 250 mg Oral Tablets
- +3 more
-
Basel, Basel-Stadt, SwitzerlandUniversity Hospital Basel
Jun 15, 2023
Ulcerative Proctitis Trial in Worldwide (Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure
Recruiting
- Ulcerative Proctitis
- Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator
- +2 more
-
Huntsville, Alabama
- +74 more
Aug 17, 2022
Congenital Adrenal Hyperplasia (CAH) Trial run by the NICHD (Flutamide, Letrozole, Hydrocortisone)
Active, not recruiting
- Congenital Adrenal Hyperplasia (CAH)
- Flutamide
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023